In a multiple logistic regression model adjusted for age, sex, systolic blood pressure, glomerular filtration rate, multivessel CAD, GRACE score at admission, initial TIMI flow, LVEF at 6 months, or concomitant use of GP IIb–IIIa inhibitors, TA was associated with a significant reduction in 30-month mortality (adjusted OR: 7.36, 95% CI: 1.20–45.10, P = 0.031). Here, ITGA2B is linked to coronary artery disorder.